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Purpose: Myopia (shortsightedness) is one of the most common ocular conditions worldwide and results in blurred
distance vision. It is a complex trait influenced by both genetic and environmental factors. We have previously reported
linkage of myopia to a 13.01 cM region of chromosome 2q37 in three large multigenerational Australian families that
initially overlapped with the known myopia locus, MYP12. The purpose of this study was to perform fine mapping of
this region and identify single nucleotide polymorphisms (SNPs) associated with myopia.
Methods: Fine mapping linkage analysis was performed on three multigenerational families with common myopia to
refine the previously mapped critical interval. SNPs in the region were also genotyped to assess for association with
myopia using an independent case-control cohort.
Results: The disease interval was refined to a 1.83 cM region that is adjacent to rather than overlapping with the MYP12
locus. Subsequent sequencing of all known and hypothetical genes as well as an association study using an independent
myopia case-control cohort showed suggestive but not statistically significant association to two intronic SNPs.
Conclusions: We have identified a novel locus for common myopia on chromosome 2q37.
Shortsightedness  is  one  of  the  most  common  eye
conditions clinically manifesting as blurred distance vision. It
results when light rays entering the eye are focused in front of
rather than on the retina. Prevalence rates for myopia range
from 20%–25% in Western countries to over 80% in the
urbanized  populations  of  Singapore,  China,  Japan,  and
Taiwan  [1-6].  Myopia  can  be  clinically  defined  using
spherical  equivalent  (SphE)  measurements  that  are
quantitated  using  diopter  (D)  measurements.  Individuals
having readings of −0.5 D or less in both eyes are considered
to be myopic [7]. Clinically, myopia can be classified as
common (SphE ≤−0.5 to <−6 D) or high grade (SphE ≤−6 D).
The more severe grades of myopia are associated with an
increased  risk  of  sight  threatening  complications  such  as
glaucoma, retinal changes, and cataract [7,8]. Due to the high
prevalence of myopia worldwide together with the increased
risk  of  visual  morbidity  from  associated  complications,
myopia  is  a  significant  public  health  problem.  As  a
consequence, the search for risk factors involved in myopia is
paramount if we are to gain insights into its pathogenesis and
reduce its burden on health.
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Myopia is a complex trait influenced by both genetic and
environmental  factors  [9].  Environmental  factors  such  as
reading (near work) are known to influence the development
of myopia but appear to account for only 12% of the observed
phenotypic  variance  [10].  The  remaining  influences  on
myopia have been suggested to relate to genes as heritability
studies  indicate  that  between  50%–94%  of  population
variance  is  accounted  for  by  genetic  factors  [11-15].  In
support  of  these  heritability  studies,  familial  correlation
studies have shown that children with myopic parents have a
four times greater risk of developing myopia than children
with non-myopic parents [16]. In addition, genetic mapping
studies  have  identified  at  least  18  chromosomal  regions
suspected of harboring a myopia gene (MYP1–MYP18). Of
these  regions,  11  have  been  implicated  in  high  myopia
(MYP1–  MYP5,  MYP11,  MYP12,  MYP13,  MYP15,
MYP16,  MYP18)  [17-28]  and  seven  in  common  myopia
(MYP6–MYP10, MYP14, MYP17) [29-31]. Five of these loci
(MYP2,  MYP3,  MYP6,  MYP10,  MYP13)  have  been
confirmed through replication studies in independent family
studies  [32-38].  Recently,  we  reported  replication  of  the
MYP12  locus  using  three  multigenerational  Australian
families [39]. The MYP12 locus was initially reported as
harboring  a  gene  for  high  grade  myopia  whereas  our
replication study indicated that this locus may also harbor a
gene for milder forms of myopia.
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722We  now  present  fine  mapping  data  for  these  three
Australian  myopia  families  that  has  refined  the  mapped
myopia  interval  to  a  region  on  chromosome  2q37  that  is
adjacent  to  but  not  overlapping  the  MYP12  locus.  Our
findings suggest this is a novel locus for myopia that is distinct
from  MYP12.  Furthermore,  we  have  undertaken  an
independent association study to identify potential genetic
variants that may be associated with myopia.
METHODS
Subjects: The three families used in this study were recruited
as part of the Genes In Myopia (GEM) Study (Melbourne,
Australia),  and  details  regarding  their  ocular  examination
have  been  previously  reported  [40].  These  families  had
previously  undergone  a  10  cM  genome-wide  scan  that
identified a myopia susceptibility locus to chromosome 2q37
[39]. DNA from all consenting family members was collected
from venous blood samples as previously described [41]. For
the current study, we defined myopic individuals as family
members with spherical equivalent refraction equal to or less
than −0.5 diopter sphere (DS) in both eyes and controls as
family members with measurements greater than −0.5 DS in
both eyes [42-47].
For the case-control association study, we used unrelated
individuals also recruited through the GEM Study [40], the
Blue Mountains Eye Study (BMES) [48], and the Melbourne
Visual  Impairment  Project  (VIP)  [49].  Individuals  with  a
history  of  eye  diseases  such  as  keratoconus,  age  related
macular degeneration (AMD), or a history of genetic disorders
known to predispose to myopia such as Stickler syndrome or
Marfan syndrome were excluded. Using the same definition
of what constituted myopia as used in the linkage study, we
analyzed 300 myopic and 291 control individuals in a case-
control cohort.
This study adhered to the tenets of the Declaration of
Helsinki and was approved by the Royal Victoria Eye and Ear
Hospital (Melbourne, Australia) and Westmead Hospital at
the University of Sydney (Sydney, Australia). All individuals
were of Caucasian descent and provided informed written
consent before commencement of the study.
Fine mapping linkage analysis: For fine mapping linkage
analysis,  the  starting  interval  was  defined  by  critical
recombination events observed in the three families during the
genome-wide linkage analysis [39]. This interval spanned
markers D2S396 and D2S338 on chromosome 2q37. For fine
mapping, polymorphic microsatellite markers spanning this
mapped interval were chosen from the deCODE genetic maps
[50]. Genotyping was undertaken by the Australian Genome
Research  Facility  (AGRF;  Melbourne,  Australia)  using  a
model 377 automated DNA sequencer (Applied Biosystems,
Melbourne, Australia). All available family members were
included in the genotyping. Genotype error checking was
performed  using  PedManager  version  0.9.  Multipoint
parametric  and  non-parametric  linkage  analyses  were
performed using MERLIN (version 1.1.2) [51]. In the case of
parametric linkage analysis, two autosomal dominant models
were used with phenocopy rates of 0.1 (model 1) or 0.2 (model
2), a penetrance of 0.9, and disease allele frequency of 0.0133.
The choice of these models was based on those described by
Chen et al. [15] in the initial linkage paper for these families.
Haplotypes were generated using MERLIN (version 1.1.2)
[51]  and  visualized  using  HaploPainter  (version  027beta)
[52].
Candidate  gene  sequencing  in  the  fine  mapped  region:
Identification  of  all  known  and  hypothetical  genes  in  the
refined  interval  was  achieved  by  mining  Ensembl  [53],
National Centre for Biotechnology Information (NCBI), and
University  of  California  Santa  Cruz  (UCSC)  Genome
Browser [54]. Bidirectional DNA sequencing was undertaken
for all predicted and known exonic regions of these genes and
at least 20 bp into each adjacent intron. DNA sequencing was
performed in six myopic individuals (two randomly chosen
from  each  of  the  three  families)  as  well  as  six  unrelated
controls  (married-in  individuals).  Primer  design,  template
amplification, and DNA sequencing was performed by the
Australian Genome Research Facility (Brisbane, Australia).
Sequencing data was visualized using Chromas Lite (version
2.01) and ClustalX (version 2.0) [55] to identify any variations
from  the  reference  sequence  deposited  in  the  Ensembl
database (reference sequence) [53]. The reference sequence
for the known single nucleotide polymorphisms (SNPs) was
defined by the common allele for the CEU (Utah residents
with ancestry from northern and western Europe) population.
Following candidate gene screening, a subset of SNPs of
interest were identified and chosen for further analysis in an
independent case-control association study. SNPs that were
present in only one of the six samples were not present in each
of the three families or were present in an equal number of
myopic  individuals  and  controls  were  excluded  from
subsequent genotype analysis.
Case-control  association  study:  The  subset  of  SNPs  that
fulfilled the above criteria was genotyped in an independent
cohort of unrelated individuals of Caucasian descent. A total
of  300  individuals  with  myopia  and  291  controls  were
genotyped  at  the  Australian  Genome  Research  Facility
(Brisbane,  Australia)  using  the  MassArray  platform
(Sequenom Inc., San Diego, CA) and matrix assisted laser
desorption/ionization-time of flight (MALDI-TOF) analysis
(Sequenom,  San  Diego,  CA).  To  provide  more  extensive
coverage of intronic and intergenic regions, additional SNPs
that  were  evenly  spaced  across  the  entire  refined  linkage
interval were identified using HapMap (Build #36) [56] and
also genotyped in the case-control cohort.
Genotyping data was assessed for deviations from the
Hardy–Weinberg equilibrium using PLINK [57]. Any SNPs
not passing this test (p<0.05 in the controls) were noted and
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performed using PLINK, and adjustments for multiple testing
were  made  using  the  Bonferroni  correction.  Prospective
power calculations were performed using Episheet.
RESULTS
Fine mapping linkage analysis: Previous linkage mapping in
three  myopia  families  (GEMF0046,  GEMF0206,  and
GEMF0251)  identified  a  13.01  cM  region  at  2q37.1  that
overlapped with the high myopia locus, MYP12 [39]. A total
of  37  myopic  and  14  control  individuals  (including  three
additional  myopic  individuals  that  were  not  previously
available)  from  these  three  families  were  used  for  fine
mapping.  Fine  mapping  of  this  region  resulted  in  a  peak
parametric and non-parametric LOD score of 3.97 and 3.48,
respectively,  at  marker  D2S338  (Figure  1).  This  was  in
agreement with the location of the peak LOD scores reported
from our initial genome-wide scan. Haplotype analysis of this
region and adjacent regions (6.02 cM proximal and 11.06 cM
distal)  using  30  polymorphic  microsatellite  markers  at  an
average spacing of 1.2 cM in the families allowed significant
narrowing of the myopia disease gene region (Figure 2). A
critical recombination event in individuals 20573, 20580, and
20581 in GEMF0206 (Figure 2A) defined the distal end of the
interval to marker D2S2968. A critical recombination event
in individuals 20094 and 21490 from GEMF0046 (Figure 2B)
and in individuals 21445 and 20472 from GEMF0251 (Figure
2C) defined the proximal end of the refined critical interval to
marker D2S1397. The refined interval was identified as a 1.83
cM region on chromosome 2q37.2-2q37.3 that was distal to
but did not overlap with the adjacent MYP12 locus (Figure
3).
Candidate gene sequencing: To identify a potential causative
myopia gene or variant within the refined linkage interval, we
identified all known and hypothetical genes in this 1.83 cM
interval. A total of eight hypothetical (BX647589, AK00798,
AK056246,  AK023507,  LOC728074,  LOC728087,
LOC728067, Q9UFF6) and six known (ankyrin repeat and
SOCS  box-containing  [ASB18],  centaurin  gamma  2
[CENTG2], COP9 constitutive photomorphogenic homolog
subunit 8 [Arabidopsis; COPS8], chemokine (C-X-C) motif
receptor 7 [CXCR7], IQ motif containing with AAA domain
[IQCA], and gastrulation brain homeobox 2 [GBX2]) genes
were identified.
DNA sequencing was undertaken on all 67 exons and
exon-intron boundaries in the known and hypothetical genes
that were localized to the refined linkage interval. The intron-
exon  structure  for  the  hypothetical  genes  was  defined  by
aligning  predicted  mRNA  sequences  with  genomic  DNA
using the BLAST algorithm. The exons were divided into 109
amplicons  and  sequenced  bidirectionally  in  six  myopic
individuals from the three GEM families and six controls (no
myopia). Overall sequencing success was 94% with seven
amplicons located in genes CXCR7 (exon 1 and 2), IQCA
(exon 17), and GBX2 (exon 1) proving difficult to sequence.
From the successfully sequenced amplicons, a total of 77
SNPs were identified where at least one individual had a
genotype that varied from the Ensembl reference sequence.
Through  the  use  of  our  exclusion  criteria  listed  under
Methods, this list of SNPs was narrowed to a total of 38. To
allow for complete SNP coverage of the refined interval, we
also  identified  all  the  known  HapMap  (Build  23a)  SNPs
located in the difficult to sequence amplicons and added these
to our list of candidate SNPs. This brought the total number
of SNPs from the hypothetical and known genes to 39.
In addition to the 39 SNPs in the known and hypothetical
genes,  information  from  HapMap  was  used  to  identify
additional intronic and intergenic SNPs in the refined interval.
Using this approach, 120 additional SNPs across the entire
refined interval as well as the region 561 kb proximal and 835
Figure  1.  LOD  Scores  for  the  fine
mapping  linkage  analysis  on
chromosome  2q37.  Parametric  (solid
line)  and  nonparametric  (dashed  line)
LOD  scores  are  shown  for  the  three
GEM families (GEM0046, GEM0251,
and GEM0206).
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724Figure 2. Haplotype analysis in the chromosome 2q37 linkage region for the three GEM families. Haplotype analysis in the chromosome 2q37
linkage region is shown for GEM0206 (A), GEM0046 (B), and GEM0251 (C).
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725kb distal to the critical recombination events were chosen.
These were selected to ensure they were evenly spaced and
covered the entire region. There was an approximate spacing
of 4–55 kb (average 51 kb) between each SNP.
Case-control association study: A total of 159 (39+120) SNPs
were  genotyped  in  an  independent  case-control  cohort
consisting of 300 myopic and 291 control individuals from
Australia. Power calculations were undertaken and suggested
that a cohort of this size will have 80% power to detect an odds
ratio of 1.78. The average genotyping success rate for these
SNPs was 98.1%. A total of eight SNPs (5.0%) were found
not  to  be  in  Hardy–Weinberg  equilibrium  and  so  were
excluded from further analysis. An additional 14 SNPs (8.8%)
were  not  polymorphic  in  this  cohort,  and  they  were  also
excluded from further analysis leaving 137 SNPs for the case-
control  association  analysis.  The  22  excluded  SNPs  were
scattered throughout the linked region with no bias for one
gene or genomic segment. All p values from the case-control
association study for the remaining 137 SNPs underwent a
Bonferroni correction. Using a conservative significance level
of 5×10−4, we observed no statistically significant association
to the genotyped SNPs [58].
DISCUSSION
Using a fine mapping linkage based approach, we have been
able to identify a novel locus for myopia on chromosome
2q37. Initially, this region was described as overlapping with
the  known  high  grade  myopia  locus,  MYP12.  However,
further fine mapping and haplotype analyses have enabled us
to better refine this region to a smaller 1.83 cM segment on
chromosome 2q37. Hence, the locus harboring the causative
myopia gene in these GEM families is novel and distinct from
the MYP12 locus, indicating a degree of genetic heterogeneity
in this region of chromosome 2. Detailed SNP analysis and
DNA sequencing of all known and hypothetical genes in the
refined interval provided no evidence of a causative variant in
the coding region of these genes. The best evidence for a
causative  variant  in  the  region  was  provided  by  the  two
intronic SNPs of rs1986830 and rs4663724, but these only
showed  suggestive  rather  than  statistically  significant
association.
Despite  strong  evidence  for  a  hereditary  component
influencing myopia, identification of causative genes or DNA
variants has so far proven difficult to achieve. To date, five
genes,  transforming  growth  factor  beta  induced  factor
homeobox 1 (TGIF) [59], paired box 6 (PAX6) [60], collagen,
type 1, alpha 1 (COL1A1) [61], hepatocyte growth factor
(HGF) [62], and uromodulin-like 1 (UMODL1) [27], have
been  positively  associated  with  high  grade  myopia  and
collagen,  type  2,  alpha  1  (COL2A1)  [63]  with  common
myopia. Of these six candidates, TGIF and COL1A1 can be
excluded as candidates as subsequent replication studies have
been negative [64-67]. COL2A1,HGF, and UMODL1 have
each been reported in single studies and await replication. The
final gene, PAX6, has been positively associated with high
grade myopia in two independent studies, but results have
been negative for common myopia [29,63,68,69]. Hence, to
date,  PAX6,  HGF,  and  UMODL1  remain  the  strongest
candidates for high grade myopia and COL2A1 for common
myopia.
The methodological approach that we have taken to gene
identification, namely linkage analysis and DNA sequencing,
mirrors the approach that has been used in many other studies
mapping myopia loci [70-73]. Unfortunately, these studies
have also failed to find a causative variant in the coding region
of candidate genes. Given that myopia is a complex disease,
it is possible that causative variants are located in intron or
flanking regulatory regions as has been demonstrated for other
complex diseases such as breast cancer, type 2 diabetes, and
chronic kidney disease [74-76]. More detailed assessment of
Figure 3. Ideogram of human chromosome 2 showing the location
of the newly fine mapped region relative to the original linkage
region  and  MYP12.  Fine  mapping  linkage  analysis  now  clearly
indicates that the region of interest is adjacent to but does not overlap
MYP12.
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726non-coding regions in these linked regions may provide more
clues as to the genetic drivers of myopia. SNPs located in the
non-coding  sequence  may  affect  gene/protein  expression
indirectly by affecting gene regulation and hence may be
important  drivers  of  the  disease  process.  Given  this,  we
extended our assessment of the candidate region to include
intronic and intergenic SNPs spanning the linkage interval.
Our study has identified a relatively small linkage region
on the long arm of chromosome 2 that represents a novel locus
for common myopia. Further analysis of this region failed to
convincingly  identify  genetic  variants  associated  with
myopia. However, there are a total of 1,048 known SNPs in
the  refined  linkage  interval,  and  we  cannot  rule  out  the
possibility that additional SNPs in this region are associated
with myopia. There are also several other issues that should
be considered when interpreting our findings. One could argue
that  the  cohort  we  used  for  the  case-control  study  was
underpowered to detect all variants that might be positively
associated with myopia. While this is a possibility, the variants
that are most likely to be missed are those that have small
effect sizes. Although such variants may still contribute to
myopia, they are likely to be only minor players. Furthermore,
it is also important to be able to assess segregation of SNPs in
the  original  GEM  families  used  in  the  linkage  analysis.
However, the relatively small number of families used for this
study  would  make  segregation  analysis  statistically
underpowered,  and  consequently,  reliable  data  cannot  be
generated. We were aware of this study limitation from the
onset and as a consequence, opted instead to validate SNPs in
an  independent  case-control  cohort  to  replicate  the  initial
linkage result.
The  findings  presented  here  do  not  represent  the
conclusion  of  this  study  but  do  provide  ongoing  data  for
further investigation into the exact genetic causes of myopia.
Further work needs to be undertaken to extend these findings
to ensure complete coverage of this region. SNP genotyping
also needs to be confirmed in a larger case-control cohort and
also replicated in additional cohorts of both Caucasian and
different ethnicities. Clearly, much more work is needed to
further  elucidate  the  underlying  genetic  influences  on  the
development of myopia.
ACKNOWLEDGMENTS
The authors wish to thank participants from the GEM, BMES,
and VIP studies who made this work possible. This work was
supported by the Australian Federal Government through the
Cooperative Research Centres Program, the Joan and Peter
Clemenger Trust, the Angior Family Foundation, the Myra
Stoicescu Trust, the William Buckland Foundation, the Eye
Research Australia Foundation, the Sunshine Foundation, the
Helen  Macpherson  Smith  Trust,  the  National  Health  and
Medical Research Council (grant number 529912), and the
L.E.W. Carty Trust. The authors wish to state that there are
no conflicts of interest.
REFERENCES
1. Wang Q, Klein BEK, Klein R, Moss SE. Refractive Status in
the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1994;
35:4344-7. [PMID: 8002254]
2. He M, Huang W, Zheng Y, Huang L, Ellwein LB. Refractive
error  and  visual  impairment  in  school  children  in  rural
southern China. Ophthalmology 2007; 114:374-82. [PMID:
17123622]
3. Katz J, Tielsch JM, Sommer A. Prevalence and risk factors for
refractive  errors  in  an  adult  inner  city  population.  Invest
Ophthalmol Vis Sci 1997; 38:334-40. [PMID: 9040465]
4. Raju P, Ramesh SV, Arvind H, George R, Baskaran M, Paul
PG, Kumaramanickavel G, McCarty C, Vijaya L. Prevalence
of refractive errors in a rural South Indian population. Invest
Ophthalmol Vis Sci 2004; 45:4268-72. [PMID: 15557431]
5. Saw SM, Gazzard G, Koh D, Farook M, Widjaja D, Lee J, Tan
DTH.  Prevalence  rates  of  refractive  errors  in  Sumatra,
Indonesia.  Invest  Ophthalmol  Vis  Sci  2002;  43:3174-80.
[PMID: 12356821]
6. Wu SY, Nemesure B, Leske MC. Refractive errors in a black
adult  population:  The  Barbados  Eye  Study.  Invest
Ophthalmol Vis Sci 1999; 40:2179-84. [PMID: 10476781]
7. Curtin  BJ.  The  Myopias:  basic  science  and  clinical
management. Philadelphia: Harper and Row; 1985.
8. Mitchell P, Wang JJ. Diabetes, fasting blood glucose and age-
related maculopathy: The Blue Mountains Eye Study. Aust N
Z J Ophthalmol 1999; 27:197-9. [PMID: 10484190]
9. Mutti DO, Zadnik K, Adams AJ. Myopia. The nature versus
nurture debate goes on. Invest Ophthalmol Vis Sci 1996;
37:952-7. [PMID: 8631638]
10. Saw SM, Tan SB, Fung D, Chia KS, Koh D, Tan DTH, Stone
RA. IQ and the association with myopia in children. Invest
Ophthalmol Vis Sci 2004; 45:2943-8. [PMID: 15326105]
11. Hammond CJ, Snieder H, Gilbert CE, Spector TD. Genes and
environment in refractive error: The twin eye study. Invest
Ophthalmol Vis Sci 2001; 42:1232-6. [PMID: 11328732]
12. Dirani M, Chamberlain M, Shekar SN, Islam AF, Garoufalis P,
Chen CY, Guymer RH, Baird PN. Heritability of refractive
error and ocular biometrics: the Genes in Myopia (GEM) twin
study. Invest Ophthalmol Vis Sci 2006; 47:4756-61. [PMID:
17065484]
13. Lyhne N, Sjolie AK, Kyvik KO, Green A. The importance of
genes  and  environment  for  ocular  refraction  and  its
determiners: a population based study among 20–45 year old
twins. Br J Ophthalmol 2001; 85:1470-6. [PMID: 11734523]
14. Wojciechowski R, Congdon N, Bowie H, Munoz B, Gilbert D,
West  SK.  Heritability  of  refractive  error  and  familial
aggregation of myopia in an elderly American population.
Invest  Ophthalmol  Vis  Sci  2005;  46:1588-92.  [PMID:
15851555]
15. Chen CY, Scurrah KJ, Stankovich J, Garoufalis P, Dirani M,
Pertile KK, Richardson AJ, Mitchell P, Baird PN. Heritability
and shared environment estimates for myopia and associated
ocular biometric traits: the Genes in Myopia (GEM) family
study. Hum Genet 2007; 121:511-20. [PMID: 17205325]
16. Mutti DO, Mitchell GL, Moeschberger ML, Jones LA, Zadnik
K.  Parental  myopia,  near  work,  school  achievement,  and
children's refractive error. Invest Ophthalmol Vis Sci 2002;
43:3633-40. [PMID: 12454029]
Molecular Vision 2009; 15:722-730 <http://www.molvis.org/molvis/v15/a74> © 2009 Molecular Vision
72717. Nallasamy S, Paluru P, Devoto M, Wasserman NF, Zhou J,
Young  TL.  Genetic  linkage  of  high-grade  myopia  in  a
Hutterite  population  from  South  Dakota.  Mol  Vis  2007;
13:229-36. [PMID: 17327828]
18. Zhang Q, Guo X, Xiao X, Jia X, Li S, Hejtmancik JF. A new
locus for autosomal dominant high myopia maps to 4q22-q27
between D4S1578 and D4S1612. Mol Vis 2005; 11:554-60.
[PMID: 16052171]
19. Zhang Q, Guo X, Xiao X, Jia X, Li S, Hejtmancik JF. Novel
locus for X linked recessive high myopia maps to Xq23-q25
but  outside  MYP1.  J  Med  Genet  2006;  43:e20.  [PMID:
16648373]
20. Wojciechowski R, Moy C, Ciner E, Ibay G, Reider L, Bailey-
Wilson JE, Stambolian D. Genomewide scan in Ashkenazi
Jewish families demonstrates evidence of linkage of ocular
refraction to a QTL on chromosome 1p36. Hum Genet 2006;
119:389-99. [PMID: 16501916]
21. Naiglin L, Gazagne C, Dallongeville F, Thalamas C, Idder A,
Rascol O, Malecaze F, Calvas P. A genome wide scan for
familial high myopia suggests a novel locus on chromosome
7q36. J Med Genet 2002; 39:118-24. [PMID: 11836361]
22. Paluru P, Ronan SM, Heon E, Devoto M, Wildenberg SC,
Scavello G, Holleschau A, Makitie O, Cole WG, King RA,
Young TL. New locus for autosomal dominant high myopia
maps to the long arm of chromosome 17. Invest Ophthalmol
Vis Sci 2003; 44:1830-6. [PMID: 12714612]
23. Paluru PC, Nallasamy S, Devoto M, Rappaport EF, Young TL.
Identification of a novel locus on 2q for autosomal dominant
high-grade  myopia.  Invest  Ophthalmol  Vis  Sci  2005;
46:2300-7. [PMID: 15980214]
24. Young TL, Ronan SM, Drahozal LA, Wildenberg SC, Alvear
AB, Oetting WS, Atwood LD, Wilkin DJ, King RA. Evidence
that a locus for familial high myopia maps to chromosome
18p. Am J Hum Genet 1998; 63:109-19. [PMID: 9634508]
25. Young TL, Ronan SM, Alvear AB, Wildenberg SC, Oetting
WS, Atwood LD, Wilkin DJ, King RA. A second locus for
familial high myopia maps to chromosome 12q. Am J Hum
Genet 1998; 63:1419-24. [PMID: 9792869]
26. Young TL, Atwood LD, Ronan SM, Dewan AT, Alvear AB,
Peterson J, Holleschau A, King RA. Further refinement of the
MYP2 locus for autosomal dominant high myopia by linkage
disequilibrium analysis. Ophthalmic Genet 2001; 22:69-75.
[PMID: 11449316]
27. Nishizaki R, Ota M, Inoko H, Meguro A, Shiota T, Okada E,
Mok J, Oka A, Ohno S, Mizuki N. New susceptibility locus
for  high  myopia  is  linked  to  the  uromodulin-like  1
(UMODL1) gene region on chromosome 21q22.3. Eye 2009;
23:222-9. [PMID: 18535602]
28. Lam CY, Tam PO, Fan DS, Fan BJ, Wang DY, Lee CW, Pang
CP, Lam DS. Genome-wide Scan Maps a Novel High Myopia
Locus  to  5p15.  Invest  Ophthalmol  Vis  Sci  2008;
49:3768-78. [PMID: 18421076]
29. Hammond  CJ,  Andrew  T,  Mak  YT,  Spector  TD.  A
susceptibility locus for myopia in the normal population is
linked  to  the  PAX6  gene  region  on  chromosome  11:  A
genomewide scan of dizygotic twins. Am J Hum Genet 2004;
75:294-304. [PMID: 15307048]
30. Stambolian D, Ibay G, Reider L, Dana D, Moy C, Schlifka M,
Holmes T, Ciner E, Bailey-Wilson JE. Genomewide Linkage
Scan  for  Myopia  Susceptibility  Loci  among  Ashkenazi
Jewish Families Shows Evidence of Linkage on Chromosome
22q12.  Am  J  Hum  Genet  2004;  75:448-59.  [PMID:
15273935]
31. Ciner  E,  Wojciechowski  R,  Ibay  G,  Bailey-Wilson  JE,
Stambolian  D.  Genomewide  scan  of  ocular  refraction  in
African-American  families  shows  significant  linkage  to
chromosome  7p15.  Genet  Epidemiol  2008;  32:454-63.
[PMID: 18293391]
32. Zhang Q, Li S, Xiao X, Guo X. Confirmation of a genetic locus
for X-linked recessive high myopia outside MYP1. J Hum
Genet 2007; 52:469-72. [PMID: 17351708]
33. Lam DSC, Tam POS, Fan DS, Baum L, Leung YF, Pang CP.
Familial  high  myopia  linkage  to  chromosome  18p.
Ophthalmologica 2003; 217:115-8. [PMID: 12592049]
34. Stambolian D, Ciner EB, Reider LC, Moy C, Dana D, Owens
R,  Schlifka  M,  Holmes  T,  Ibay  G,  Bailey-Wilson  JE.
Genome-wide scan for myopia in the Old Order Amish. Am
J Ophthalmol 2005; 140:469-76. [PMID: 16084785]
35. Farbrother JE, Kirov G, Owen MJ, Pong-Wong R, Haley CS,
Guggenheim JA. Linkage analysis of the genetic loci for high
myopia  on  18p,  12q,  and  17q  in  51  UK  families.  Invest
Ophthalmol Vis Sci 2004; 45:2879-85. [PMID: 15326098]
36. Stambolian D, Ibay G, Reider L, Dana D, Moy C, Schlifka M,
Holmes TM, Ciner E, Bailey-Wilson JE. Genome-wide scan
of additional Jewish families confirms linkage of a myopia
susceptibility locus to chromosome 22q12. Mol Vis 2006;
12:1499-505. [PMID: 17167407]
37. Klein AP, Duggal P, Lee KE, Klein R, Bailey-Wilson JE, Klein
BE.  Confirmation  of  linkage  to  ocular  refraction  on
chromosome 22q and identification of a novel linkage region
on 1q. Arch Ophthalmol 2007; 125:80-5. [PMID: 17210856]
38. Nurnberg G, Jacobi FK, Broghammer M, Becker C, Blin N,
Nurnberg P, Stephani U, Pusch CM. Refinement of the MYP3
locus on human chromosome 12 in a German family with
Mendelian autosomal dominant high-grade myopia by SNP
array  mapping.  Int  J  Mol  Med  2008;  21:429-38.  [PMID:
18360688]
39. Chen CY, Stankovich J, Scurrah KJ, Garoufalis P, Dirani M,
Pertile KK, Richardson AJ, Baird PN. Linkage replication of
the MYP12 locus in common myopia. Invest Ophthalmol Vis
Sci 2007; 48:4433-9. [PMID: 17898262]
40. Garoufalis P, Chen CYC, Dirani M, Couper TA, Taylor HR,
Baird PN. Methodology and recruitment of probands and their
families for the Genes in Myopia (GEM) Study. Ophthalmic
Epidemiol 2005; 12:383-92. [PMID: 16283990]
41. Richardson AJ, Narendran N, Guymer RH, Vu H, Baird PN.
Blood storage at 4 degrees C-factors involved in DNA yield
and  quality.  J  Lab  Clin  Med  2006;  147:290-4.  [PMID:
16750666]
42. Wong TY, Foster PJ, Hee J, Ng TP, Tielsch JM, Chew SJ,
Johnson  GJ,  Seah  SKL.  Prevalence  and  risk  factors  for
refractive  errors  in  adult  Chinese  in  Singapore.  Invest
Ophthalmol Vis Sci 2000; 41:2486-94. [PMID: 10937558]
43. Guzowski M, Wang JJ, Rochtchina E, Rose KA, Mitchell P.
Five-year refractive changes in an older population - The Blue
Mountains Eye Study. Ophthalmology 2003; 110:1364-70.
[PMID: 12867393]
44. Mutti DO, Zadnik K. Age-related decreases in the prevalence
of  myopia:  Longitudinal  change  or  cohort  effect?  Invest
Ophthalmol Vis Sci 2000; 41:2103-7. [PMID: 10892850]
Molecular Vision 2009; 15:722-730 <http://www.molvis.org/molvis/v15/a74> © 2009 Molecular Vision
72845. Wensor  M,  McCarty  CA,  Taylor  HR.  Prevalence  and  risk
factors of myopia in Victoria, Australia. Arch Ophthalmol
1999; 117:658-63. [PMID: 10326965]
46. Rose  K,  Smith  W,  Morgan  I,  Mitchell  P.  The  increasing
prevalence  of  myopia:  implications  for  Australia.  Clin
Experiment  Ophthalmol  2001;  29:116-20.  [PMID:
11446448]
47. Junghans B, Kiely PM, Crewther DP, Crewther SG. Referral
rates  for  a  functional  vision  screening  among  a  large
cosmopolitan  sample  of  Australian  children.  Ophthalmic
Physiol Opt 2002; 22:10-25. [PMID: 11824644]
48. Attebo K, Ivers RQ, Mitchell P. Refractive errors in an older
population - The blue mountains eye study. Ophthalmology
1999; 106:1066-72. [PMID: 10366072]
49. Taylor HR, Livingston PM, Stanislavsky YL, McCarty CA.
Visual impairment in Australia: Distance visual acuity, near
vision, and visual field findings of the Melbourne Visual
Impairment Project. Am J Ophthalmol 1997; 123:328-37.
[PMID: 9063242]
50. Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson
SA, Richardsson B, Sigurdardottir S, Barnard J, Hallbeck B,
Masson G, Shlien A, Palsson ST, Frigge ML, Thorgeirsson
TE,  Gulcher  JR,  Stefansson  K.  A  high-resolution
recombination map of the human genome. Nat Genet 2002;
31:241-7. [PMID: 12053178]
51. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin–
rapid analysis of dense genetic maps using sparse gene flow
trees. Nat Genet 2002; 30:97-101. [PMID: 11731797]
52. Thiele  H,  Nurnberg  P.  HaploPainter:  a  tool  for  drawing
pedigrees  with  complex  haplotypes.  Bioinformatics  2005;
21:1730-2. [PMID: 15377505]
53. Flicek P, Aken BL, Beal K, Ballester B, Caccamo M, Chen Y,
Clarke L, Coates G, Cunningham F, Cutts T, Down T, Dyer
SC, Eyre T, Fitzgerald S, Fernandez-Banet J, Graf S, Haider
S, Hammond M, Holland R, Howe KL, Howe K, Johnson N,
Jenkinson A, Kahari A, Keefe D, Kokocinski F, Kulesha E,
Lawson D, Longden I, Megy K, Meidl P, Overduin B, Parker
A, Pritchard B, Prlic A, Rice S, Rios D, Schuster M, Sealy I,
Slater G, Smedley D, Spudich G, Trevanion S, Vilella AJ,
Vogel J, White S, Wood M, Birney E, Cox T, Curwen V,
Durbin R, Fernandez-Suarez XM, Herrero J, Hubbard TJ,
Kasprzyk A, Proctor G, Smith J, Ureta-Vidal A, Searle S.
Ensembl  2008.  Nucleic  Acids  Res  2008;  36:D707-14.
[PMID: 18000006]
54. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH,
Zahler  AM,  Haussler  D.  The  human  genome  browser  at
UCSC. Genome Res 2002; 12:996-1006. [PMID: 12045153]
55. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins
DG. The CLUSTAL_X windows interface: flexible strategies
for multiple sequence alignment aided by quality analysis
tools.  Nucleic  Acids  Res  1997;  25:4876-82.  [PMID:
9396791]
56. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs
RA,  Belmont  JW,  Boudreau  A,  Hardenbol  P,  Leal  SM,
Pasternak S, Wheeler DA, Willis TD, Yu F, Yang H, Zeng C,
Gao Y, Hu H, Hu W, Li C, Lin W, Liu S, Pan H, Tang X,
Wang J, Wang W, Yu J, Zhang B, Zhang Q, Zhao H, Zhou J,
Gabriel SB, Barry R, Blumenstiel B, Camargo A, Defelice M,
Faggart M, Goyette M, Gupta S, Moore J, Nguyen H, Onofrio
RC, Parkin M, Roy J, Stahl E, Winchester E, Ziaugra L,
Altshuler D, Shen Y, Yao Z, Huang W, Chu X, He Y, Jin L,
Liu Y, Sun W, Wang H, Wang Y, Xiong X, Xu L, Waye MM,
Tsui SK, Xue H, Wong JT, Galver LM, Fan JB, Gunderson
K, Murray SS, Oliphant AR, Chee MS, Montpetit A, Chagnon
F, Ferretti V, Leboeuf M, Olivier JF, Phillips MS, Roumy S,
Sallee C, Verner A, Hudson TJ, Kwok PY, Cai D, Koboldt
DC, Miller RD, Pawlikowska L, Taillon-Miller P, Xiao M,
Tsui  LC,  Mak  W,  Song  YQ,  Tam  PK,  Nakamura  Y,
Kawaguchi  T,  Kitamoto  T,  Morizono  T,  Nagashima  A,
Ohnishi Y, Sekine A, Tanaka T, Tsunoda T, Deloukas P, Bird
CP,  Delgado  M,  Dermitzakis  ET,  Gwilliam  R,  Hunt  S,
Morrison J, Powell D, Stranger BE, Whittaker P, Bentley DR,
Daly MJ, de Bakker PI, Barrett J, Chretien YR, Maller J,
McCarroll S, Patterson N, Pe'er I, Price A, Purcell S, Richter
DJ, Sabeti P, Saxena R, Schaffner SF, Sham PC, Varilly P,
Stein LD, Krishnan L, Smith AV, Tello-Ruiz MK, Thorisson
GA, Chakravarti A, Chen PE, Cutler DJ, Kashuk CS, Lin S,
Abecasis GR, Guan W, Li Y, Munro HM, Qin ZS, Thomas
DJ, McVean G, Auton A, Bottolo L, Cardin N, Eyheramendy
S, Freeman C, Marchini J, Myers S, Spencer C, Stephens M,
Donnelly P, Cardon LR, Clarke G, Evans DM, Morris AP,
Weir BS, Mullikin JC, Sherry ST, Feolo M, Skol A, Zhang
H, Matsuda I, Fukushima Y, Macer DR, Suda E, Rotimi CN,
Adebamowo  CA,  Ajayi  I,  Aniagwu  T,  Marshall  PA,
Nkwodimmah C, Royal CD, Leppert MF, Dixon M, Peiffer
A, Qiu R, Kent A, Kato K, Niikawa N, Adewole IF, Knoppers
BM, Foster MW, Clayton EW, Watkin J, Muzny D, Nazareth
L, Sodergren E, Weinstock GM, Yakub I, Birren BW, Wilson
RK, Fulton LL, Rogers J, Burton J, Carter NP, Clee CM,
Griffiths M, Jones MC, McLay K, Plumb RW, Ross MT, Sims
SK,  Willey  DL,  Chen  Z,  Han  H,  Kang  L,  Godbout  M,
Wallenburg JC, L'Archeveque P, Bellemare G, Saeki K, An
D, Fu H, Li Q, Wang Z, Wang R, Holden AL, Brooks LD,
McEwen JE, Guyer MS, Wang VO, Peterson JL, Shi M,
Spiegel J, Sung LM, Zacharia LF, Collins FS, Kennedy K,
Jamieson R, Stewart J. A second generation human haplotype
map of over 3.1 million SNPs. Nature 2007; 449:851-61.
[PMID: 17943122]
57. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA,
Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham
PC. PLINK: a tool set for whole-genome association and
population-based linkage analyses. Am J Hum Genet 2007;
81:559-75. [PMID: 17701901]
58. Colhoun HM, McKeigue PM, Davey Smith G. Problems of
reporting  genetic  associations  with  complex  outcomes.
Lancet 2003; 361:865-72. [PMID: 12642066]
59. Lam DSC, Lee WS, Leung YF, Tam POS, Fan DSP, Fan BJ,
Pang CP. TGF beta-induced factor: A candidate gene for high
myopia. Invest Ophthalmol Vis Sci 2003; 44:1012-5. [PMID:
12601022]
60. Tsai YY, Chiang CC, Lin HJ, Lin JM, Wan L, Tsai FJA. PAX6
gene polymorphism is associated with genetic predisposition
to extreme myopia. Eye 2008; 22:576-81. [PMID: 17948041]
61. Inamori Y, Ota M, Inoko H, Okada E, Nishizaki R, Shiota T,
Mok J, Oka A, Ohno S, Mizuki N. The COL1A1 gene and
high myopia susceptibility in Japanese. Hum Genet 2007;
122:151-7. [PMID: 17557158]
62. Han W, Yap MKH, Wang J, Yip SP. Family-based association
analysis  of  hepatocyte  growth  factor  (HGF)  gene
Molecular Vision 2009; 15:722-730 <http://www.molvis.org/molvis/v15/a74> © 2009 Molecular Vision
729polymorphisms in high myopia. Invest Ophthalmol Vis Sci
2006; 47:2291-9. [PMID: 16723436]
63. Mutti DO, Cooper ME, O'Brien S, Jones LA, Mariazita ML,
Murray JC, Zadnik K. Candidate gene and locus analysis of
myopia. Mol Vis 2007; 13:1012-9. [PMID: 17653045]
64. Pertile  KK,  Schache  M,  Islam  FM,  Chen  CY,  Dirani  M,
Mitchell P, Baird PN. Assessment of TGIF as a candidate
gene  for  myopia.  Invest  Ophthalmol  Vis  Sci  2008;
49:49-54. [PMID: 18172074]
65. Hasumi Y, Inoko H, Mano S, Ota M, Okada E, Kulski JK,
Nishizaki R, Mok J, Oka A, Kumagai N, Nishida T, Ohno S,
Mizuki N. Analysis of single nucleotide polymorphisms at 13
loci  within  the  transforming  growth  factor-induced  factor
gene shows no association with high myopia in Japanese
subjects.  Immunogenetics  2006;  58:947-53.  [PMID:
17048038]
66. Li J, Zhang QJ, Xiao XS, Li JZ, Zhang FS, Li SQ, Li W, Li T,
Jia XY, Guo L, Guo XM. The SNPs analysis of encoding
sequence of interacting factor gene in Chinese population.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003; 20:454-6.
[PMID: 14556208]
67. Liang CL, Hung KS, Tsai YY, Chang W, Wang HS, Juo SH.
Systematic assessment if the tagged polymorphisms of the
COL1A1  gene  for  high  myopia.  J  Hum  Genet  2007;
52:374-7. [PMID: 17273809]
68. Simpson CL, Hysi P, Bhattacharya SS, Hammond CJ, Webster
A, Peckham CS, Sham PC, Rahi JS. The Roles of PAX6 and
SOX2 in Myopia: lessons from the 1958 British Birth Cohort.
Invest  Ophthalmol  Vis  Sci  2007;  48:4421-5.  [PMID:
17898260]
69. Hewitt AW, Kearns LS, Jamieson RV, Williamson KA, van
Heyningen  V,  Mackey  DA.  PAX6  mutations  may  be
associated  with  high  myopia.  Ophthalmic  Genet  2007;
28:179-82. [PMID: 17896318]
70. Scavello GS, Paluru PC, Ganter WR, Young TL. Sequence
variants  in  the  transforming  growth  beta-induced  factor
(TGIF) gene are not associated with high myopia. Invest
Ophthalmol Vis Sci 2004; 45:2091-7. [PMID: 15223781]
71. Scavello GS Jr, Paluru PC, Zhou J, White PS, Rappaport EF,
Young TL. Genomic structure and organization of the high
grade  Myopia-2  locus  (MYP2)  critical  region:  mutation
screening of 9 positional candidate genes. Mol Vis 2005;
11:97-110. [PMID: 15723005]
72. Zhou J, Young TL. Evaluation of Lipin 2 as a candidate gene
for autosomal dominant 1 high-grade myopia. Gene 2005;
352:10-9. [PMID: 15862761]
73. Paluru PC, Scavello GS, Ganter WR, Young TL. Exclusion of
lumican and fibromodulin as candidate genes in MYP3 linked
high  grade  myopia.  Mol  Vis  2004;  10:917-22.  [PMID:
15592176]
74. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI,
Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ,
Hughes TE, Groop L, Altshuler D, Almgren P, Florez JC,
Meyer J, Ardlie K, Bengtsson Bostrom K, Isomaa B, Lettre
G, Lindblad U, Lyon HN, Melander O, Newton-Cheh C,
Nilsson  P,  Orho-Melander  M,  Rastam  L,  Speliotes  EK,
Taskinen MR, Tuomi T, Guiducci C, Berglund A, Carlson J,
Gianniny  L,  Hackett  R,  Hall  L,  Holmkvist  J,  Laurila  E,
Sjogren M, Sterner M, Surti A, Svensson M, Tewhey R,
Blumenstiel B, Parkin M, Defelice M, Barry R, Brodeur W,
Camarata J, Chia N, Fava M, Gibbons J, Handsaker B, Healy
C, Nguyen K, Gates C, Sougnez C, Gage D, Nizzari M,
Gabriel SB, Chirn GW, Ma Q, Parikh H, Richardson D, Ricke
D, Purcell S. Genome-wide association analysis identifies
loci for type 2 diabetes and triglyceride levels. Science 2007;
316:1331-6. [PMID: 17463246]
75. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson
SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J,
Yu K, Chatterjee N, Orr N, Willett WC, Colditz GA, Ziegler
RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle
EE, Thun MJ, Hayes RB, Tucker M, Gerhard DS, Fraumeni
JF Jr, Hoover RN, Thomas G, Chanock SJ. A genome-wide
association study identifies alleles in FGFR2 associated with
risk of sporadic postmenopausal breast cancer. Nat Genet
2007; 39:870-4. [PMID: 17529973]
76. Kottgen A, Kao WH, Hwang SJ, Boerwinkle E, Yang Q, Levy
D, Benjamin EJ, Larson MG, Astor BC, Coresh J, Fox CS.
Genome-wide  association  study  for  renal  traits  in  the
Framingham Heart and Atherosclerosis Risk in Communities
Studies. BMC Med Genet 2008; 9:49. [PMID: 18522750]
Molecular Vision 2009; 15:722-730 <http://www.molvis.org/molvis/v15/a74> © 2009 Molecular Vision
The print version of this article was created on 7 April 2009. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
730